Editor's Note The US Department of Health and Human Services (HHS) and Pfizer have announced an agreement to extend patient access to the COVID-19 drug Paxlovid, Healthcare Purchasing News October 16 reports. According to the article, Pfizer is readying the drug for more availability in the commercial market in November…
Editor's Note Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports. Pfizer cited a combination of factors for the shortage, including…